May 14, 2013
Concord, CA, May 14, 2013 – Biocare Medical is proud to announce the availability of a new Uroplakin II mouse monoclonal antibody (IVD). Studies have shown UP II mRNA to be expressed in both bladder cancer tissues and peripheral blood of patients with primary and metastatic urothelial carcinoma.
Urothelial carcinoma (UC) of the bladder typically originates [...]
Read more
April 17, 2013
Enhancing the VP Echelon product line, Biocare is pleased to announce the addition of p40 mouse monoclonal, Arginase-1, and Uroplakin II to our menu of prediluted antibodies optimized for the Ventana® BenchMark® XT Immunohistochemistry Staining Systems.
The mouse monoclonal antibody p40 [BC28] may have applications in cases where p63 is used. While p63 has proven to [...]
Read more
April 2, 2013
Biocare Medical would like to thank you for making the 102nd Annual United States and Canadian Academy of Pathology in Baltimore, MD a great success! Many attendees took advantage of a great opportunity to learn more about our IHC products from antibodies to instrumentation.
Biocare was proud to be involved in four poster presentations, highlighting some [...]
Read more
March 26, 2013
Biocare Medical is proud to announce the availability of a new highly specific p40 mouse monoclonal antibody (IVD). Mouse monoclonal anti-p40 [BC28] demonstrated similar sensitivity and specificity as the rabbit polyclonal p40, staining 97% (65/67) of cases of lung squamous cell carcinoma (SqCC) and 0% (0/71) cases of lung adenocarcinoma (ADC), in an in-house study. [...]
Read more
March 8, 2013
Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group and Biocare Medical, LLC (Biocare) today announced that they have entered into a non-exclusive license agreement to allow Biocare access to certain patents and materials related to p63 diagnostics in the research and IVD field. In parallel, Biocare and AsymmetRx Medical, Inc. (AsymmetRx) have [...]
Read more
October 15, 2012
Biocare Medical would like to thank you for making the 38th Annual National Society of Histotechnology in Vancouver, Canada a great success! Hundreds participated in our inaugural Histolympics, gleaning the chance to learn about immunohistochemistry and having fun at the same time.
After receiving the Biocare Olympic torch, contenders entered into a pentathlon that tested your [...]
Read more
July 5, 2012
“Don’t be arrogant, because arrogance kills curiosity.” a great TED Presentation by Mina Bissell:
http://blog.ted.com/2012/06/29/cancer-in-context-mina-bissell-at-tedglobal-2012/
Read more
March 20, 2012
-New Assay, Developed in Collaboration with Morphotek, Uses Proprietary Technology-
Concord, CA and Exton, PA, March 20, 2012 – In partnership with Morphotek® Inc., a subsidiary of Eisai Inc., Biocare Medical announced the release of its in vitro diagnostic immunohistochemical (IHC) kit to detect folate receptor alpha (FRalpha) expression in formalin fixed paraffin embedded (FFPE) [...]
Read more
